Verhoeff N P, Meyer J H, Kecojevic A, Hussey D, Lewis R, Tauscher J, Zipursky R B, Kapur S
PET Centre and Schizophrenia and Continuing Care Division, Clarke Site, Centre for Addiction and Mental Health, University of Toronto, ON, M5T 1R8, Toronto, Canada.
Psychiatry Res. 2000 Oct 30;99(3):123-35. doi: 10.1016/s0165-1781(00)00198-0.
Several postmortem studies have reported regionally localized decreases in serotonin(2A) receptors (5-HT(2A)R) in schizophrenia. This was not confirmed by two recent [18F]setoperone positron emission tomography (PET) studies. In these two studies relatively large regions of interest (ROIs) were used; hence, 5-HT(2A)R changes may have been missed in some brain areas. Therefore, data from one study were analyzed on a voxel-by-voxel basis using Statistical Parametric Mapping (SPM). We also used this method to examine the relationship between 5-HT(2A)R binding potential (BP) and five PANSS-derived factors: negative, positive, activation, dysphoric and autistic preoccupation. Thirteen schizophrenic patients (10 antipsychotic-naïve, 3 antipsychotic-free; 11 M, 2 F; age 31+/-7 years) and 35 age-matched control subjects (15 M, 20 F; age 30+/-7 years) were scanned. The 5-HT(2A)R BP was determined for each voxel using the pseudoequilibrium ratio method on PET data obtained between 65 and 90 min after [18F]setoperone bolus injection. The resulting parametric 5-HT(2A)R BP images were spatially normalized using a ligand specific template. Analyses of covariance were done using SPM99 with age as covariate. In tests for the effect of schizophrenia and for partial correlations between 5-HT(2A)R BP and the five factors, corrected P values <0.05 at cluster or voxel level were considered significant. No significant differences were detected between patients and control subjects, and no significant correlations were observed between 5-HT(2A)R BP and any of the five factors. Thus, in agreement with the previous ROI studies, voxel-by-voxel analysis confirmed the lack of substantial 5-HT(2A)R BP differences between schizophrenic patients and control subjects.
多项尸检研究报告称,精神分裂症患者的5-羟色胺(2A)受体(5-HT(2A)R)存在局部区域性减少。最近的两项[18F]司替戊醇正电子发射断层扫描(PET)研究并未证实这一点。在这两项研究中,使用了相对较大的感兴趣区域(ROI);因此,某些脑区的5-HT(2A)R变化可能被遗漏了。因此,使用统计参数映射(SPM)对一项研究的数据进行了逐体素分析。我们还使用此方法来研究5-HT(2A)R结合潜能(BP)与五个阳性和阴性症状评定量表(PANSS)衍生因子之间的关系:阴性、阳性、激活、烦躁和孤独症关注。对13名精神分裂症患者(10名未使用过抗精神病药物,3名未服用抗精神病药物;11名男性,2名女性;年龄31±7岁)和35名年龄匹配的对照受试者(15名男性,20名女性;年龄30±7岁)进行了扫描。在[18F]司替戊醇团注注射后65至90分钟之间获得的PET数据上,使用伪平衡比方法确定每个体素的5-HT(2A)R BP。使用配体特异性模板对所得的参数化5-HT(2A)R BP图像进行空间归一化。使用SPM99以年龄作为协变量进行协方差分析。在精神分裂症影响测试以及5-HT(2A)R BP与五个因子之间的偏相关性测试中,在簇或体素水平上校正后的P值<0.05被认为具有显著性。在患者和对照受试者之间未检测到显著差异,并且在5-HT(2A)R BP与五个因子中的任何一个之间均未观察到显著相关性。因此,与先前的ROI研究一致,逐体素分析证实了精神分裂症患者与对照受试者之间缺乏实质性的5-HT(2A)R BP差异。